Value of F-18 FDG PET/CT for the Prediction of EGFR Mutation in Lung Cancer Patients
NCT06520189 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2024-07-25
Summary
To detect value of F-18FDG PET/CT as a non-invasive method for the prediction of EGFR mutations in lung cancer patients.
Conditions
Interventions
- DEVICE
-
F-18 FDGPET/CT
F-18 FDGPET/CT oncology protocol for lung cancer patients
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-01
- Primary Completion
- 2028-10-01
- Completion
- 2028-10-01
More Related Trials
-
Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer
NCT05617742 ·Status: COMPLETED ·Phase: NA
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data
NCT07287904 ·Status: NOT_YET_RECRUITING
-
Application of 68Ga-labeled ACE2 Targeting Probe PET/CT Imaging in Tracing ACE2 Expression and Diagnosis of Lung Cancer
NCT06194630 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer
NCT06742021 ·Status: RECRUITING ·Phase: NA
-
Multimodalitic Imaging in the N-stage of Lung Cancer
NCT05840094 ·Status: UNKNOWN ·Phase: NA
-
Novel Detection System for Lung Cancer Curative Effect Monitoring
NCT02666755 ·Status: UNKNOWN
-
Early Lung Cancer Detection Using Computed Tomography
NCT00188734 ·Status: COMPLETED
-
99mTc-H7ND SPECT/CT Imaging in NSCLC
NCT05999214 ·Status: RECRUITING ·Phase: NA
-
PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers
NCT00136890 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer
NCT04553601 ·Status: UNKNOWN ·Phase: NA
-
Study of CT and MR in the Lung Cancer
NCT04034667 ·Status: UNKNOWN
-
Feasibility of Intratumoral Washing Fluid for Detecting EGFR Mutations in Lung Cancer
NCT05517083 ·Status: COMPLETED ·Phase: NA
-
68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC
NCT06756217 ·Status: RECRUITING
-
Application of Diffusion Weighted MRI Versus CT in Evaluation of the Effect of Treating Lung Cancer
NCT02320617 ·Status: UNKNOWN ·Phase: NA
-
Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
NCT02117440 ·Status: TERMINATED
-
The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer
NCT00364663 ·Status: UNKNOWN
-
Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment
NCT00752076 ·Status: UNKNOWN ·Phase: NA
-
PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1
NCT06738680 ·Status: NOT_YET_RECRUITING
-
AIMN Multicenter Study: 18 F-FDG PET-CT With or Without Contrast Medium in the Staging and Radiation of Lung Cancer?
NCT06168916 ·Status: COMPLETED
-
Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer
NCT06895941 ·Status: WITHDRAWN
-
A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis
NCT02803619 ·Status: UNKNOWN
-
Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer
NCT02059889 ·Status: WITHDRAWN ·Phase: NA
-
Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung Carcinoma
NCT00188279 ·Status: COMPLETED ·Phase: PHASE2
-
The Application Value of Spectral CT in the Accurate Staging of Liver Cancer
NCT06977399 ·Status: NOT_YET_RECRUITING ·Phase: NA